MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads

← catalyst calendar

NCT05199870 · readout ≤ 223 d

Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.

Phase

—

Status

Enrolling by invitation

Study type

Observational

Enrollment

116estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-03-10

actual

When the study began enrolling

Primary completion

Mar 2027

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

Mar 2027

estimated

The whole study's end, after follow-up

First posted

2022-01-20

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-03-19

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Hip Arthritis
Hip Disease
Hip Fractures
Hip Injuries
Hip Pain Chronic

Interventions

Device: RingLoc Bipolar Acetabular Cup
Device: Endo II Femoral Head

Primary outcome

what the primary-completion date above is the date OF

Device safety assessed through the frequency and incidence of revisions, complications, and Adverse Events.

measured Greater than or equal to 8 years.

Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed